Research into cancer metabolomics: Towards a clinical metamorphosis

Area of Science:

• Oncology
• Metabolomics
• Biochemistry

Background:

• Metabolic reprogramming is a hallmark of cancer, driving tumor growth and progression.
• Despite high expectations, clinical applications of targeting cancer metabolism have been limited.
• Advances in understanding tumor metabolism offer new avenues for cancer management.

Purpose of the Study:

• To provide a comprehensive overview of current and emerging strategies targeting cancer metabolism.
• To highlight the clinical, pre-clinical, and technical advancements in exploiting tumor metabolic traits.
• To discuss the future prospects and anticipations of metabolomics in cancer care.

Main Methods:

• Review of ongoing clinical trials and pre-clinical models evaluating metabolic compounds.
• Analysis of new discoveries in cancer metabolic gene alterations.
• Synthesis of information on diagnostic and therapeutic strategies targeting unique tumor metabolism.

Main Results:

• Several diagnostic and therapeutic compounds are under evaluation in clinical trials and pre-clinical studies.
• Discoveries of altered metabolic genes show potential for prognostic and clinical relevance.
• Metabolic approaches are increasingly integrated with existing cancer management strategies.

Conclusions:

• Targeting cancer metabolism holds significant promise for improving cancer diagnosis and treatment.
• Continued research in metabolomics is expected to yield further clinical applications.
• Exploiting unique tumor metabolic traits represents a vital frontier in oncology.